Apomorphine in malignant syndrome due to levodopa withdrawal
- PMID: 1592579
- DOI: 10.1007/BF02226968
Apomorphine in malignant syndrome due to levodopa withdrawal
Abstract
We report a case of neuroleptic malignant syndrome (NMS) following abrupt reduction of chronic levodopa treatment in a 71 year old female parkinsonian patient. The NMS resolved within 24 hours of the addition of apomorphine to levodopa therapy.